🇺🇸 FDA
Patent

US 12414981

JNK inhibitors for use in treating and preventing neurodegenerative disorders

granted A61KA61K38/1709A61P

Quick answer

US patent 12414981 (JNK inhibitors for use in treating and preventing neurodegenerative disorders) held by Northwestern University expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/1709, A61P, A61P25/28